Display options
Cite
See K, Manser R, Park ER, et al. The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey. ERJ Open Res. 2020;6(1)doi: 10.1183/23120541.00158-2019.
See, K., Manser, R., Park, E. R., Steinfort, D., King, B., Piccolo, F., & Manners, D. (2020). The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey. ERJ open research, 6(1), . https://doi.org/10.1183/23120541.00158-2019
See, Katharine, et al. "The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey." ERJ open research vol. 6,1 (2020). doi: https://doi.org/10.1183/23120541.00158-2019
See K, Manser R, Park ER, Steinfort D, King B, Piccolo F, Manners D. The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey. ERJ Open Res. 2020 Mar 16;6(1). doi: 10.1183/23120541.00158-2019. eCollection 2020 Jan. PMID: 32201692; PMCID: PMC7073421.
Copy Download .nbib Format: NLM
Share it on

ERJ Open Res. 2020 Mar 16;6(1). doi: 10.1183/23120541.00158-2019. eCollection 2020 Jan.

The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey.

ERJ open research

Katharine See, Renee Manser, Elyse R Park, Daniel Steinfort, Bridget King, Francesco Piccolo, David Manners

Affiliations

  1. Dept of Respiratory Medicine, Northern Hospital, Epping, Victoria, Australia.
  2. Dept of Respiratory and Sleep Medicine, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  3. Dept of Medicine (Royal Melbourne Hospital), University of Melbourne, Victoria, Australia.
  4. Dept of Medical Oncology and Haematology, Peter MacCallum Cancer Centre, Parkville, Victoria, Australia.
  5. Harvard Medical School, Massachusetts General Hosptial, Boston, MA, USA.
  6. Midland Physician Service, St John of God Midland Private and Public Hospitals, Midland, Western Australia, Australia.
  7. Curtin Medical School, Curtin University, Bentley, Western Australia, Australia.

PMID: 32201692 PMCID: PMC7073421 DOI: 10.1183/23120541.00158-2019

Abstract

Lung cancer screening is effective at reducing lung cancer deaths when individuals at greatest risk are screened. Recruitment initiatives target all current and former smokers, of whom only some are eligible for screening, potentially leading to discordance between screening preference and eligibility in ineligible individuals. The objective of the present study was to identify factors associated with preference for screening among ever-smokers. Ever-smokers aged 55-80 years attending outpatient clinics at three Australian hospitals were invited. The survey recorded: 1) demographics; 2) objective lung cancer risk and screening eligibility using the Prostate Lung Colon Ovarian 2012 risk model; and 3) perceived lung cancer risk, worry about and seriousness of lung cancer using a validated questionnaire. Multivariable ordinal logistic regression identified predictors of screening preference. The survey was completed by 283 individuals (response rate 27%). Preference for screening was high (72%) with no significant difference between low-dose computed tomography screening-eligible and -ineligible individuals (77%

Copyright ©ERS 2020.

Conflict of interest statement

Conflict of interest: K. See has nothing to disclose. Conflict of interest: R. Manser has nothing to disclose. Conflict of interest: E.R. Park has nothing to disclose. Conflict of interest: D. Steinfo

References

  1. Ann Intern Med. 2014 Mar 4;160(5):330-8 - PubMed
  2. Chest. 2013 Dec;144(6):1783-1787 - PubMed
  3. PLoS Med. 2014 Dec 02;11(12):e1001764 - PubMed
  4. Ann Am Thorac Soc. 2016 Nov;13(11):1969-1976 - PubMed
  5. JAMA Intern Med. 2017 Mar 1;177(3):439-441 - PubMed
  6. Intern Med J. 2018 Jan;48(1):78-80 - PubMed
  7. Nicotine Tob Res. 2014 Feb;16(2):166-73 - PubMed
  8. Thorax. 2007 Feb;62(2):126-30 - PubMed
  9. Ann Behav Med. 2009 Jun;37(3):268-79 - PubMed
  10. Int J Cancer. 2017 Jul 15;141(2):242-253 - PubMed
  11. JAMA Oncol. 2017 Sep 1;3(9):1278-1281 - PubMed
  12. Nicotine Tob Res. 2014 Jun;16(6):899-903 - PubMed
  13. CMAJ. 2016 Apr 5;188(6):425-432 - PubMed
  14. Lung Cancer Int. 2013;2013:789057 - PubMed
  15. Lung Cancer. 2019 Jul;133:32-37 - PubMed

Publication Types